Monoclonal RhD prophylaxis: high time to evaluate efficacy.
Verweij E, Tura AK, Gure T, Pyuza J, Mchome B, Kawaza K, Moons P, de Winter D, Van't Oever R, Spitalnik S, van der Schoot CE, van den Akker T; AFRICARhE consortium.
Verweij E, et al. Among authors: tura ak.
Lancet. 2024 Mar 2;403(10429):806-807. doi: 10.1016/S0140-6736(23)01888-3.
Lancet. 2024.
PMID: 38431342
No abstract available.